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p62 overexpression induces TDP‑43 
cytoplasmic mislocalisation, 
aggregation and cleavage 
and neuronal death
A. D. Foster1,2,8, L. L. Flynn3,4,8, C. Cluning1, F. Cheng5, J. M. Davidson5, A. Lee5, N. Polain3,4, 
R. Mejzini3,4, N. Farrawell6, J. J. Yerbury6, R. Layfield7, P. A. Akkari3,4 & S. L. Rea2,3,4*
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) that exist on a 
spectrum of neurodegenerative disease. A hallmark of pathology is cytoplasmic TDP‑43 aggregates 
within neurons, observed in 97% of ALS cases and ~ 50% of FTLD cases. This mislocalisation from the 
nucleus into the cytoplasm and TDP‑43 cleavage are associated with pathology, however, the drivers 
of these changes are unknown. p62 is invariably also present within these aggregates. We show that 
p62 overexpression causes TDP‑43 mislocalisation into cytoplasmic aggregates, and aberrant TDP‑43 
cleavage that was dependent on both the PB1 and ubiquitin‑associated (UBA) domains of p62. We 
further show that p62 overexpression induces neuron death. We found that stressors (proteasome 
inhibition and arsenic) increased p62 expression and that this shifted the nuclear:cytoplasmic TDP‑
43 ratio. Overall, our study suggests that environmental factors that increase p62 may thereby 
contribute to TDP‑43 pathology in ALS and FTLD.
Abbreviations
ALS  Amyotrophic lateral sclerosis
FTLD  Frontotemporal lobar degeneration
PB1  Phox and bemp1
UBA  Ubiquitin-associated
NF-κB  Nuclear factor kappa b
SOD1  Superoxide dismutase 1
MEFs  Mouse embryonic fibroblasts
DMEM  Dulbecco’s modified essential medium
EGFP  Enhanced Green Fluorescent Protein
PBS  Phosphate buffered saline
LC–MS  Liquid Chromatography Mass spectrometry
NaAsO2  Sodium arsenite
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are genotypically, phenotypi-
cally and pathologically related neurodegenerative diseases that are now referred to as part of a disease  spectrum1. 
ALS, the most common form of motor neuron disease, is a progressive and ultimately lethal disorder with an 
average life expectancy of 2–3 years post  diagnosis2. FTLD is a leading cause of early onset dementia. Although 
most cases (~ 90%) of both diseases are sporadic (having no known familial involvement), the pathology and 
phenotypic presentation of sporadic cases are, for the most part, indistinguishable to inherited forms. The exact 
aetiology of ALS and FTLD remains unclear, however, research over the past few decades indicates that several 
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mechanisms may play a role in pathobiology. These include dysfunctional protein homeostasis through changes 
to autophagy or lysosomal function or the ubiquitin–proteasome system, endoplasmic reticulum stress, dys-
functional mitochondria and/or energy metabolism, increased oxidative stress, impaired axonal transport and 
trafficking defects and dysfunctional RNA-binding  proteins2,3.
A key characteristic of ALS and FTLD is the presence of cytoplasmic aggregates containing TDP-43 in neu-
rons, present in 97% of ALS cases, familial and sporadic, and ~ 50% of FTLD cases, indicating a common final 
 pathway4. TDP-43 aggregates are also found in other neurodegenerative and neuromuscular conditions (e.g. 
Alzheimer’s disease and inclusion body myositis). Mutations in TARDBP, coding for TDP-43, are a rare cause 
of ALS and  FTLD5,6. In familial and sporadic cases, the TDP-43 observed in affected tissue is found in cytoplas-
mic aggregates and is aberrantly phosphorylated, ubiquitinated and  cleaved7. TDP-43 is normally a primarily 
nuclear protein, with roles in mRNA translation, splicing and cryptic exon retention, nuclear export, and axon 
 outgrowth4. The cytoplasmic mislocalisation of TDP-43 is considered an important pathogenic mechanism 
in ALS and FTLD that is likely to impact diverse biological processes that reduce neuronal  viability4. TDP-43 
pathology may be due to both loss and gain of  function8–10. Abnormal nuclear depletion of TDP-43 causes a 
loss of splicing function in neurons leading to widespread transcriptome changes, including altered  splicing11 
and also leads to defects in DNA double-strand  repair12. TDP-43 cytoplasmic aggregation and cleavage leads to 
toxic gain of function  phenotypes13.
TDP-43 positive protein aggregates in ALS and FTLD often also contain p62  protein14–17. The consistent pres-
ence of p62 in pathological inclusions and the identification of Sequestosome1/p62 mutations as a rare cause of 
ALS and FTLD suggest a role in  pathogenesis18. p62 shuttles ubiquitinated proteins to the proteasome or to the 
autophagy-lysosomal system for degradation and regulation of signalling pathways that are induced by oxidative 
stress (Nrf2) and nerve growth factor (nuclear factor kappa b, NF-κB). p62 facilitates the degradation of proteins 
implicated in neurodegenerative diseases, including mutant superoxide dismutase 1 (SOD1) in  ALS19 and tau 
in Alzheimer’s, and  FTLD20. Further to roles in autophagy and the ubiquitin proteasome system the adaptor 
protein regulates transcription factors. p62 is a scaffold protein in NF-κB signalling pathways important for 
neuronal differentiation and  survival21. Oxidative damage to the p62 promoter is associated with neurodegen-
erative diseases, p62 knockout mice develop dementia-like symptoms, and loss of p62 caused a syndrome that 
includes childhood  neurodegeneration22,23. Together, these studies suggest that increasing p62 levels may be of 
therapeutic benefit. However, previous studies highlight that p62 knockout can enhance neuron survival or that 
p62 expression can be  detrimental24,25. It remains unclear whether p62 expression is harmful or helpful in the 
context of ALS and FTLD. Here, we describe that overexpression of p62 leads to TDP-43 cellular mislocalisation, 
cleavage and aggregation and leads to neuronal death.
Results
Over‑expression of p62 causes mislocalisation and nuclear depletion of wild type 
TDP‑43. TDP-43 is the main component of protein aggregates in ALS and non-tau related FTLD. p62 is 
invariably also observed in cytoplasmic protein aggregates within surviving neurons in neurodegenerative dis-
eases including ALS and FTLD, and p62 and TDP-43 were co-immunoprecipitated from FTLD-affected  tissue17. 
Thus, we wondered if p62 expression or its aggregation within the cytoplasm might affect TDP-43 localisa-
tion. We observed that overexpression of EGFP-p62WT with TDP-43-tdTomatoWT in motor neuron-like NSC-34 
cells causes TDP-43 nuclear depletion with localisation shifting into cytoplasmic aggregates. Co-localisation of 
TDP-43 with the nuclear stain was significantly reduced in cells expressing EGFP-p62WT compared with those 
expressing EGFP alone (p =  < 0.001) with Pearson’s co-efficient of 0.508 ± 0.047 versus 0.786 ± 0.021. (Fig. 1). A 
Pearson’s co-efficient of > 0.6 indicates co-localisation, thus p62 overexpression significantly reduced TDP-43 
co-localisation with the nucleus. We investigated the effects of increasing concentrations of EGFP-p62WT by 
transfecting cells with 0.5, 1 or 2 reflect µg of expression construct and observed that all concentrations led to 
TDP-43-tdTomatoWT mislocalisation and cytoplasmic aggregation (Supplementary Fig. 1).
As p62 and TDP-43 often co-localise with ubiquitin in ALS and FTLD tissue, and p62 recognises ubiqui-
tinated proteins via its ubiquitin-associated (UBA) domain, we investigated whether nuclear mislocalisation 
of TDP-43 was dependent on the UBA domain. Of note, several SQSTM1/p62 mutations reported in ALS and 
FTLD patients manifest within the UBA domain (Reviewed  in18) and have previously been shown to reduce 
ubiquitin-binding  capacity26. We found that co-expression of EGFP-p62ΔUBA with TDP-43-tdTomato did not 
lead to mislocalisation and nuclear depletion of TDP-43, as co-localisation with the nucleus was unaffected by 
EGFP-p62ΔUBA over-expression (Pearson’s co-efficient of 0.651 ± 0.036). Of note, we observed that TDP-43 in 
the cytoplasm formed a distinct shell surrounding EGFP-p62WT (Fig. 1, inset, arrows), this phenomenon was 
not observed with co-expression of EGFP-p62ΔUBA.
p62 shifts TDP‑43 solubility in an UBA‑dependent manner. We observed that TDP-43 mislocali-
sation from the nucleus seemed to be associated with p62 foci, as TDP-43 visually formed a shell around p62 
puncta. Thus, we performed fractionation of cellular proteins into a soluble and an insoluble (containing protein 
aggregates) fraction to determine the effects of p62 on TDP-43 aggregation (Fig. 2).
Consistent with the visual assessment of p62 puncta that we observed in our confocal experiments, EGFP-
p62WT was predominantly present in the insoluble fraction, whereas EGFP-p62ΔUBA was predominantly present 
in the soluble fraction. This fits with our observations that the EGFP-p62ΔUBA mutant was principally expressed 
in a diffuse pattern within the cytoplasm. We found that co-expression with EGFP-p62WT, but not EGFP-p62ΔUBA, 
decreased the soluble:insoluble ratio of wild type TDP-43 (p = 0.01); which appears to be due to the decreased 
soluble TDP-43 in cells, EGFP-p62WT p = 0.080 (Fig. 2). The total TDP-43 was not significantly different in 
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EGFP-p62 (WT or ∆UBA) expressing cells compared to those transfected with EGFP control cells, suggesting 
that p62 expression did not affect turnover of TDP-43WT (Table 1).
Nuclear TDP‑43 is significantly decreased in  p62+/+ compared with  p62−/− cells. We confirmed 
our finding that p62 expression is an important factor that regulates TDP-43 localisation using mouse embry-
onic fibroblasts (MEFs) with  (p62+/+) and without p62  (p62−/−). The amount of nuclear TDP-43 was increased in 
 p62−/− cells compared with  p62+/+, thus increasing the nuclear:cytoplasmic ratio (Fig. 3A–C). Because p62 aggre-
gates are observed in ALS, FTLD and other neurodegenerative disorders, we hypothesised that environmental 
risk factors for these diseases may increase p62 expression and this could lead to TDP-43 cytoplasmic mislocali-
sation. In support of this hypothesis, previous literature shows that head trauma, which may be a risk factor for 
Figure 1.  Expression of EGFP-p62 causes TDP-43WT cytoplasmic mislocalisation in a UBA domain dependent 
manner. Cells co-expressing TDP-43WT and either EGFP or EGFP-p62 (WT or ΔUBA) were fixed and stained 
with Hoechst then visualized by confocal microscopy. Arrows show TDP-43 forming a shell around wild type 
p62 (inset). Three independent experiments were performed. Cells expressing both TDP-43-tdTomato and 
EGFP construct were imaged from random fields of view with a minimum of 10 cells imaged per experiment. 
TDP-43-tdTomato co-localisation with the nucleus was determined by calculating the Pearson’s co-efficient with 
ImageJ. Post-hoc ANOVA Bonferroni test was performed in SPSS.
Figure 2.  p62 expression alters TDP-43 solubility. Cells were transfected with TDP-43WT and either EGFP, 
EGFP-p62WT or EGFP-p62ΔUBA (as indicated), and 48 h post-transfection cells were lysed in Triton-X buffer 
(soluble). Triton-X insoluble pellets were solubilized with SDS (insoluble). Western blot analyses with GFP, RFP 
and α-tubulin antibodies were performed. Image is representative of 3 independent experiments.
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ALS and  FTLD27–29, increases p62 expression leading to p62/TDP-43 aggregation in  neurons30,31. To confirm the 
role of p62 in TDP-43 localisation we used  p62+/+ and  p62−/− MEFs. We treated cells with a proteasome inhibitor 
(MG132), sodium arsenate (NaAsO2) or heat shock and observed that MG132 and arsenic both increased p62 
expression in  p62+/+ cells (Fig. 3D). This was associated with an increase in the amount of cytoplasmic TDP-43 
observed (Fig. 3E). While MG132 increased the level of cytoplasmic TDP-43 in  p62−/− MEFs,  NaAsO2 did not, 
indicating that p62 is required for arsenate but not MG132-induced TDP-43 mislocalisation.
p62 overexpression induces TDP‑43 cleavage to create a disease‑associated 35‑kDa frag‑
ment. Cleaved TDP-43 products of 35- and 25-kDa have been identified in ALS and  FTLD28. Aggregation 
of the 35-kDa fragment, but not the 25-kDa fragment, induced cytoplasmic inclusions that recruited full length 
TDP-43 and inhibited RNA  processing32. We investigated the effect of increasing p62 expression on TDP-43 
aggregation and cleavage. We observe that as p62 overexpression is increased, more TDP-43 becomes insoluble. 
Further, we observed the production of a cleaved 90-kDa TDP-43-tdTomato fragment (Fig. 4). As tdTomato 
is ~ 55 kDa and is a C-terminal tag in this construct, this fragment presumably corresponds to a cleaved C-ter-
minal 35-kDa product of TDP-43 (TDP-35).
Table 1.  Expression of EGFP-p62 reduces TDP-43 solubility in a UBA-dependent manner.
Soluble Insoluble Sol:Insol Total
EGFP-p62WT ↓p = 0.080 n.s
↓
p = 0.01 n.s
EGFP-p62∆UBA n.s n.s n.s n.s
Figure 3.  p62 alters the nuclear:cytoplasmic TDP-43 ratio. Mouse embryonic fibroblasts (A) with p62 
knockdown  (p62−/−) and (B) without  (p62+/+) were treated with proteasome inhibitor (MG132), sodium arsenate 
or heat shock followed by recovery. Cells were fractionated into nuclear and cytosol fractions and proteins 
separated by SDS polyacrylamide gel electrophoresis. Western blots for endogenous p62, TDP-43 and α-tubulin 
were performed. (C) The ratio of nuclear: cytoplasmic TDP-43 in non-treated  p62−/− cells presented as a fold-
change normalised to  p62+/+ non-treated cells (set to 1.0) and (D) the amount of p62 in  p62+/+ with indicated 
treatments. (E) The ratio of nuclear:cytoplasmic TDP-43 in treated  p62+/+ cells presented as a fold-change 
normalised to  p62+/+ non-treated cells (set to 1.0). Images are representative of 4 independent experiments. Data 
presented in (C), (D) and (E) are the mean +/− SEM of 4 independent experiments.
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Proteasome inhibition and p62 overexpression induce cleavage of TDP‑43. Cleavage of TDP-43 
can be mediated by caspase-3 or calpains and may be a precursor to its degradation. TDP-43 can be degraded 
by either the proteasome or the autophagy-lysosomal pathway with p62 reportedly targeting TDP-43 to  both33. 
As this study suggested that p62 mediates TDP-43 degradation, we further investigated whether p62-induced 
TDP-43 cleavage was associated with TDP-43 degradation. We co-expressed TDP-43WT with EGFP-p62WT and 
24 h post-transfection treated cells with MG132, serum starved cells to induce autophagy or serum starved and 
Bafilomycin A1 treated cells to inhibit lysosomal degradation. We did not see any significance differences in the 
amount of total TDP-43, a combination of that present in the soluble and insoluble fractions (full-length and 
cleaved), in cells overexpressing EGFP-p62WT compared with cells overexpressing EGFP. Thus, in the time frame 
of our experiment 48 h post-transfection EGFP-p62WT overexpression, and the subsequent cleavage of TDP-43 
to TDP-35, did not enhance TDP-43 degradation (Fig. 5).
These four tryptic peptides of TDP-43 mapped to regions corresponding to amino acids 85–414 (C-terminal 
region) of TDP-43, indicating that the N-terminal region of TDP-43 was presumably cleaved (Supplementary 
Figs. 5–8).
As a control, we also excised a region on the protein gel corresponding to where endogenous TDP-43 migrates 
from HEK293 lysate and identified predominately tryptic peptides that mapped to the N-terminal region of TDP-
43 (Supplementary Fig. 9). This suggests that the band matching 90-kDa TDP-43-tdTomato (TDP-35-tdTomato) 
was cleaved at the N-terminus, which possibly could be attributed to a Caspase-3 dependent “DETD” recognition 
site at amino acids 85–8930. TDP-43 is also cleaved by calpains, therefore we next investigated whether the cleav-
age was in fact dependent on caspases or calpains using inhibitors. Cells were pre-treated with caspase inhibitor 
or a calpain inhibitor prior to transfection with expression constructs for TDP-43-tdTomato and either EGFP or 
EGFP-p62. Cells were maintained with the inhibitors for 48 h and then subjected to fractionation. The amount of 
TDP-35-tdTomato observed in the insoluble fraction of EGFP-p62 expressing cells treated with caspase inhibitor 
was not significantly different to that in the lysates obtained from non-treated cells (Fig. 7). The amount of TDP-
35-tdTomato in calpain inhibitor treated EGFP-p62 expressing cells was lower than was present in non-treated 
cells, however this is likely a reflection of reduced total TDP-43.
p62 overexpression induces neuronal cell death. While previous studies have shown that p62 knock-
down causes  neurodegeneration22,23, overexpression of p62 in an ALS SOD1 mouse exacerbated  disease24. 
Because we have observed that p62 overexpression leads to TDP-43 mislocalisation, aggregation and cleavage, 
known signs of pathology in ALS and FTLD, we hypothesised that p62 overexpression may be detrimental to 
neurons. Therefore, we performed cell viability assays. NSC-34 cells were transfected with tagged-empty vector 
controls or EGPP-p62WT with TDP-43WT or with tdTomato empty vector control. We assessed cell viability at 
48, 72 and 96 h post transfection and observed significant cell death at each time point (Fig. 8). The percent-
age of viable cells decreased from ~ 90% in cells expressing controls to 56.83% (p = 0.0009), 58.27% (p = 0.0004) 
and 48.3% (p = 0.0018) with EGFP-p62WT expression alone at 48, 72 and 96 h post transfection, respectively. In 
cells expressing both TDP-43WT and EGFP-p62WT this was further reduced to 42.73% (p < 0.0001) and 32.97% 
(p = 0.0004) at 72 and 96 h post transfection, respectively.
Next we investigated whether the effects of p62 overexpression on cell viability were dependent on TDP-43. 
To this end, we transfected cells with phosphorodiamidate morpholino oligomers (PMOs) used routinely in our 
laboratory to knock-down expression of TDP-43, or a control PMO (Fig. 9). We found that the toxic effects of 
Figure 4.  p62 expression induces TDP-43 cleavage to a 35-kDa fragment. Cells were transfected with constant 
TDP-43-tdTomato with increasing amounts of EGFP-p62 (0, 0.25, 0.5, 1, 1.5 or 2 μg) and decreasing amounts of 
EGFP (2, 1.75, 1.5, 1, 0.5 or 0 μg) to maintain consistent DNA amounts across transfection. Cells were then lysed 
in Triton-X buffer (soluble) and Triton-X insoluble pellets were solubilized with SDS (insoluble). Western blots 
for GFP, RFP and α-tubulin were performed as indicated. Image is representative of 3 independent experiments.
6
Vol:.(1234567890)
Scientific Reports |        (2021) 11:11474  | https://doi.org/10.1038/s41598-021-90822-2
www.nature.com/scientificreports/
Figure 5.  p62 creates a cleaved TDP-43 species that is also induced by proteasomal inhibition. Cells were 
transfected with TDP-43-tdTomato and either pcDNA3.1 (A) or EGFP-p62 (B). Cells were treated with 
proteasome inhibitor MG132, serum starved, serum starved with Bafilomycin A1 or left untreated. Cells were 
lysed and soluble and insoluble fractions obtained. Western blots were performed as indicated. Red dashed 
boxes indicate the presence of a *TDP-43-tdTomato cleavage product (TDP-35-tdTomato). The TDP-35 band 
from pcDNA3.1 transfected MG132-treated cells and EGFP-p62 non-treated cells was excised, trypsin-digested 
and analysed by mass spectrometry (Fig. 6). However, we did observe that the presumed TDP-35 fragment 
induced by EGFP-p62WT overexpression was also present in the lysates from EGFP expressing cells that were 
treated with the MG132. These protein bands were excised for LC–MS/MS analysis and we identified four 
tryptic peptides to confirm that the band matching 90-kDa TDP-tdTomato was indeed a cleavage product of 
TDP-43 (Fig. 6).
Figure 6.  Identified tryptic peptides from TDP-43. The 90 kDa-tdTomato-TDP43 bands from cells transfected 
with the empty vector treated with MG132 (A) and overexpressed with p62 (B) were excised and underwent 
tryptic digestion. Peptide analysis indicated that the fragments consist of the C-terminal aa85-414 of TDP-43.
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overexpressing p62 was not significantly different between cells transfected with TDP-43 knock-down PMOs 
compared with control PMO transfected cells.
p62‑mediated depletion of nuclear TDP‑43 alters RNA splicing and regulation.. We wanted to 
know the effects of p62 overexpression on TDP-43 mediated RNA regulation. To determine whether p62-medi-
ated TDP-43 cleavage and cytoplasmic aggregation leads to a loss of functional nuclear TDP-43, we evaluated 
the pre-mRNA splicing and regulation of known TDP-43 RNA targets. RT-PCR across the Stag2, Poldip3, and 
Madd transcripts was carried out on RNA from NSC-34 cells transfected with the p62 overexpression plasmid 
or an empty vector control, following a 1, 3 or 5-day incubation (Fig. 10). There was a 6% increase in Stag2 
transcripts containing exon 30b (+ 30b) in the p62 transfected cells after 3 and 5 days compared with empty 
vector transfected cells, with 39% of + 30b transcripts compared to 33% within the empty vector transfected cells 
(Fig. 10A). We observed a decrease in the number of transcripts skipping exon 3 (Δ3) in Poldip3 following p62 
overexpression, with 47% exon 3 skipping compared to 54% in the empty vector control after 5 days (Fig. 10B). 
An amplicon above the full length Poldip3 (FL) transcript was observed and deemed to be a PCR artefact. Fol-
lowing p62 overexpression, we observed up to a 10% decrease in the full-length Madd transcript after 5 days, 
when normalised to Smn loading (Fig. 10C).
The PB1 and UBA domains and the nuclear export sequence of p62 are required for TDP‑43 
cleavage. In order to determine which regions of p62 are required for TDP-43 pathology, we co-expressed 
TDP-43-tdTomato with EGFP-p62 deletion constructs and fractionated cells into soluble and insoluble frac-
tions. We found that overexpression of an EGFP-p62 protein consisting of the PB1 and the UBA domains only 
(Δ122–386) or expression of a mutant protein incapable of self-dimerisation (K7A/D69A) induced TDP-43 
cleavage to a similar extent as expression of EGFP-p62WT (Fig. 11). However, in contrast to expression of EGFP-
p62WT, expression of EGFP-p62∆PB1 (lacking the PB1 domain (124–440), the UBA domain (1–385) or the nuclear 
export sequence (Δ303–320) did not induce TDP-43 cleavage to a TDP-35 C-terminal fragment (Fig. 8). While 
expression of the PB1 domain alone (1–122) was not sufficient to induce significant cleavage of TDP-43, expres-
sion of a PB1 and UBA domain only construct (∆122–386) did induce some cleavage. Thus, the PB1 domain, the 
nuclear export sequence and the UBA domain are required for TDP-43 cleavage.
The PB1 and UBA domains, but not the nuclear export sequence, of p62 are required for 
TDP‑43 cytoplasmic mislocalisation. Overexpression of EGFP-p62∆PB1 or EGFP-p62∆UBA failed to 
mislocalise TDP-43 or cause nuclear depletion, however overexpression of the PB1 and UBA domains alone 
Figure 7.  p62-mediated cleavage of TDP-43 is independent of caspases. NSC-34 cells were pre-treated with 
20 μM caspase inhibitor, 5 μM calpain inhibitor or were left untreated for 1 h and then transfected with TDP-
43-tdTomato and either EGFP or EGFP-p62. Cells were maintained in media containing the inhibitor for 48 h 
and then harvested for soluble and insoluble fractions. Western blot analyses for TDP-43 (anti-RFP), EGFP and 
α-tubulin were performed. TDP-43 bands were quantified using ImageJ and the amount of TDP-35-tdTomato 
fragment observed in the insoluble fraction of EGFP versus EGFP-p62 expressing cells was compared with SPSS.
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Figure 8.  Expression of p62 causes neuronal death. Cells were transfected with EGFP empty vector (EGFP-EV) 
and RFP empty vector (RFP-EV), EGFP-p62 with or without TDP-43-tdTomato (RFP-TDP) or TDP-43-
tdTomato with EGFP-EV. At (A) 48, (B) 72 or (C) 96 h post-transfection cells were trypsinised and incubated 
with Sytox-Red and assessed for cell viability by flow cytometry, (D) percentage viability of cells expressing 
EGFP-p62 + RFP-EV compared to EGFP-EV + RFP-EV expressing cells at each time point. Data is the mean of 3 
independent experiments +/− SEM.
Figure 9.  p62-mediated neuronal death is independent of TDP-43 expression. (A) Cells were transfected 
with a PMO to knock-down TDP-43 (TDP-43 KD) or a standard control (GTC). The following day cells were 
transfected with EGFP-p62 and 48 h later trypsinised, incubated with Sytox-Red and then assessed for cell 
viability by flow cytometry. (B) Cells were harvested at 3 and 5 days post transfection with PMOs and western 
blots performed as indicated.
9
Vol.:(0123456789)
Scientific Reports |        (2021) 11:11474  | https://doi.org/10.1038/s41598-021-90822-2
www.nature.com/scientificreports/
(EGFP-p62Δ123–385) was not sufficient to cause significant TDP-43 nuclear depletion (Fig. 9). We observed that 
the nuclear export sequence and the self-oligomerisation function of the PB1 domain are not required for TDP-
43 mislocalisation to the cytoplasm (Fig. 12). Thus, while the PB1 and UBA domains and the nuclear export 
sequence were required for TDP-43 cleavage, only the PB1 and UBA domains are required for mislocalisation 
and p62-induced TDP-43 pathology is not dependent on p62 self-dimerisation.
Discussion
The mislocalisation of TDP-43 away from the nucleus and into cytoplasmic aggregates in neuronal cells is a 
hallmark of ALS and non-tau related FTLD. These protein aggregates invariably also contain p62, which is 
thought to be a marker of dysregulated proteostasis. The cause of protein aggregation and its potential role as 
either a cytoprotective or cytotoxic process has long been debated and is still  unclear34. As p62 and TDP-43 are 
both constituents of these pathogenic cytoplasmic protein aggregates, and co-precipitate from diseased  tissue17, 
we wondered if altered p62 expression may affect TDP-43 localisation or aggregation. We show that p62 overex-
pression causes a shift of TDP-43 out of the nucleus and into the cytoplasm, where it forms a shell-like structure 
surrounding aggregates of p62. However, overexpression of p62 lacking either the PB1 or the UBA domains failed 
to induce TDP-43 cytoplasmic mislocalisation or aggregation, suggesting that they are required domains for 
the induction of TDP-43 pathology. Of note, we show that the self-oligomerisation function of the PB1 domain 
is not required for mislocalisation to occur. As this function is required for the role of p62 in autophagy, this 
suggests that the aggregates formed are not destined for protein degradation via this pathway. We confirmed the 
importance of p62 as a regulator of TDP-43 localisation using  p62−/− MEFs. The amount of nuclear TDP-43 and 
the nuclear:cytoplasmic ratio was increased in these cells compared to wild type counterparts  (p62+/+) provid-
ing further evidence that p62 expression depletes nuclear TDP-43 by shifting TDP-43 into the cytoplasm. It is 
not clear exactly how this occurs however, p62 may interact with TDP-43 via its PB1 domain, and/or recognize 
ubiquitinated TDP-43 via its UBA domain, thereby inducing mislocalisation and aggregation.
It is unclear whether the ALS and FTLD pathology associated with TDP-43 is due to loss of nuclear function 
or gain of toxic cytoplasmic functions. We hypothesised that p62 overexpression, leading to TDP-43 nuclear 
depletion, may cause changes in TDP-43 mediated splicing events. We investigated the effects of we p62 overex-
pression in neuronal cells on TDP-43-mediated RNA regulation. Loss of functional TDP-43 within the nucleus 
has previously been reported to induce the retention of exon 30b within the STAG2 mature  RNA35, exon 3 skip-
ping from POLDIP336 and regulation of MADD35 in human neuronal cells. We amplified Stag2, Poldip3, and 
Madd transcripts from RNA extracted from NSC-34 cells transfected with the p62 overexpression plasmid or 
an empty vector control, at 1, 3 or 5-days post transfection. Consistent with TDP-43 knockdown in previous 
reports, there was an increase in Stag2 transcripts containing exon 30b in the p62 transfected cells after 3 and 
5 days, compared with the empty vector transfected cells. Additionally, we observed a decrease in the full-length 
Madd transcript after 5 days. The moderate effect size that we observed may be due to low transfection efficiency 
in NSC-34 cells (~ 20–30%), such that only a subset of the total RNA extracted is from cells overexpressing p62. 
Figure 10.  p62 overexpression leads to loss of TDP-43-mediated RNA regulation. Effects of p62 overexpression 
on alternative splicing of selected genes, showing RT-PCRs across Stag2 (A), Poldip3 (B) and Madd (C) 
transcripts following transfection with p62 overexpression vector (p62) or the empty vector control (EV) and 
incubated for 1, 3 and 5 days. An RT-PCR across Smn transcripts were used as a loading control. A 100 bp 
ladder was loaded on either side of the gel and a no template control (NTC) was included in the final lane. Full-
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We found, in contrast to previous reports, a decrease in the number of transcripts skipping exon 3 (Δ3) in Poldip3 
following p62 overexpression compared with empty vector transfected cells at 5 days. Nonetheless, our find-
ings are interesting as while changes in regulation of Stag2 and Madd transcripts following p62 overexpression 
supports a loss of functional nuclear TDP-43, the splicing of Poldip3 in mouse neurons was inconsistent with a 
previous  report36. This may be due to differential splicing patterns and regulation between species. In support 
of this, TDP-43 regulation of STMN2 cryptic splicing in ALS patient neurons was not observed in the  mouse37.
In order to assess the effects of p62 overexpression on TDP-43 aggregation and possible toxic cytoplasmic gain 
of function we performed cell fractionation studies after co-expressing p62 (wild type or UBA deficient, ΔUBA) 
with TDP-43 and found that p62 wild type overexpression reduced the amount of soluble TDP-43 and increased 
the soluble:insoluble ratio. This suggests that expression of p62 may either induce TDP-43 degradation, thereby 
decreasing the soluble TDP-43 observed, or p62 may shift TDP-43 expression into insoluble protein aggregates. 
It appears to be the latter, as the total amount of wild type TDP-43 (combined soluble and insoluble, full-length 
and cleaved) was unchanged in cells overexpressing EGFP-p62 compared with cells expressing EGFP. Taken 
together, our experiments suggest that p62 is shifting TDP-43 localisation from a soluble nuclear fraction into 
an insoluble cytoplasmic fraction, rather than inducing degradation of TDP-43. To investigate this further we 
performed experiments to determine the effects of p62 overexpression on TDP-43 turnover. We treated cells with 
a proteasome inhibitor (MG132), serum starvation (to induce autophagy) or serum starvation with Bafilomycin 
treatment (to inhibit lysosomal degradation) followed by cell fractionation into soluble and insoluble fractions. 
In keeping with our previous observations, these studies did not reveal significant changes in the amount of total 
TDP-43 (soluble and insoluble combined) in cells over-expressing EGFP-p62 compared with EGFP expressing 
cells. However, a previous report has shown that p62 expression induced TDP-43  degradation33. It may be that 
the time frame of our experiments monitoring TDP-43 turnover was insufficient to observe the effects of p62 
expression on TDP-43 degradation.
In addition to cytoplasmic mislocalisation and aggregation, TDP-43 cleavage is associated with ALS and FTLD 
 pathology38. We observed that p62 overexpression induced TDP-43-tdTomato cleavage into a 90-kDa fragment. 
Given that the tdTomato tag is C-terminal and is ~ 55-kDa, this means the fragment corresponds to a C-terminal 
Figure 11.  TDP-43 aggregation and cleavage require the PB1 and UBA domains, and the nuclear export signal 
of p62. NSC-34 cells were transfected with TDP-43-tdTomato and EGFP-p62 wild type [WT] or mutants as 
indicated. (A) Schematic diagram of p62 domain structure and deletion mutants: 1–122 (PB1 domain only), 
124–440 (lacks the PB1 domain), 1–385 (lacks the UBA domain), Δ122–386 (PB1 and UBA domains only), 
Δ303–320 (lacks the nuclear export sequence) and K7A/D69A (self-dimerization mutant). (B) Soluble and 
insoluble fractions were prepared and separated by SDS-PAGE and transferred to nitrocellulose membranes. 
Western blot analyses were performed as indicated. Image is representative of 3 independent experiments.
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TDP-43 protein of ~ 35-kDa. Our TDP-43 turnover experiments revealed that this cleaved TDP-43 fragment 
was also produced in control EGFP-expressing cells, but only following treatment with a proteasome inhibitor, 
whereas this fragment was observed in lysates from cells expressing EGFP-p62 under all treatment conditions 
including in the lysates from untreated cells. Thus, proteasome inhibition and overexpression of EGFP-p62 lead 
to TDP-43 cleavage. Importantly a C-terminal 35-kDa fragment has been identified in patients and is associated 
with aggregation and loss of  function32,38. Thus p62-induced cleavage of TDP-43 may be important in ALS and 
FTLD pathology. We excised the bands containing cleaved TDP-43 from our control, MG132 treated cells and 
the bands from untreated cells expressing p62 and subjected them to tryptic digestion and mass spectrometry. 
We determined that the fragment corresponds to amino acids 85–414 of TDP-43.
We performed a literature search of TDP-43 cleavage and found that both calpain and caspase-3 can lead 
to TDP-43 cleavage to a 35-kDa  fragment39,40. The cleavage sites for calpain is in the C-terminus of TDP-43, 
and we determined by mass spectrometry that our cleavage site is in the N-terminus, thus it seemed unlikely 
that the TDP-35 fragment observed is mediated by calpain cleavage. TDP-43 contains a Caspase-3 dependent 
“DETD” recognition site, with cleavage occurring between amino acids 84–8541. Thus, we investigated whether 
p62-mediated cleavage of TDP-43 was dependent on calpain or caspases, using specific inhibitors. The amount 
of the cleavage product, TDP-35-tdTomato, in cells expressing EGFP-p62 was not significantly different in lysates 
from caspase inhibitor treated cells compared with untreated cells. However, in EGFP-p62 expressing cells treated 
with a calpain inhibitor the amount of TDP-35-tdTomato observed in the insoluble fraction was reduced com-
pared to non-treated cells expressing EGFP-p62. This could suggest that the TDP-43 cleavage that is induced by 
p62 overexpression is partly dependent on calpains, but not caspases, however it is more likely a reflection of the 
reduced total TDP-43 that we observed in calpain-treated cells. It is possible that pre-treatment with the calpain 
Figure 12.  TDP-43 nuclear depletion requires the PB1 and UBA domains of p62, but not the nuclear export 
signal or self-dimerisation via the PB1 domain. (A) NSC-34 cells were transfected with TDP-43-tdTomato and 
EGFP empty vector (EGFP-EV) or EGFP-p62 (WT or deletion constructions as indicated). Cells were fixed 
and stained with the nuclear stain Hoechst. Images are representative of 3 independent experiments. Minimum 
number of cells analysed per construct = 32. (B) TDP-43-tdTomato co-localisation with the nucleus was 
determined by calculating the Pearson’s co-efficient with ImageJ. Statistical analyses were performed using SPSS, 
with Bonferroni and Dunnet T3, p = 0.05. #compared with EGFP-EV, *compared with EGFP-p62 WT.
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inhibitor prior to transfections reduced the transfection efficiency thereby reducing the total TDP-43 and the 
TDP-35 fragment observed. Thus, we interpret our results to be consistent with the notion that p62-mediated 
TDP-43 cleavage occurs via another mechanism that is independent of both caspases and calpains.
Our results show that p62 overexpression induced signs of TDP-43 pathology and we confirmed an important 
role for p62 in TDP-43 localisation using  p62−/− MEFs, which showed significantly increased nuclear TDP-43 
when compared with  p62+/+ MEFs. As p62 is a stress-induced gene we hypothesise that stressors associated 
ALS, such as cigarette smoking or exposure to  pesticides42, or proteasomal or oxidative  stress43,44 may induce 
p62 expression and thereby lead to TDP-43 pathology. Here, we show that proteasome inhibition and exposure 
to the heavy metal arsenite induced p62 expression and this was associated with increased levels of cytoplasmic 
TDP-43. We also show that p62 overexpression induced neuronal death. However, we found that this cell death 
was independent of TDP-43 expression as knock-down of TDP-43 did not significantly reduce the cell death 
observed. Thus, while increased levels of p62 leads to TDP-43 mislocalisation and aggregation and misregulation 
of RNA transcripts in neurons, p62 appears to induce cell death via additional TDP-43 independent pathways.
Concluding remarks. Our results show that p62-induced cleavage of TDP-43 requires the PB1 domain, 
the UBA domain and the nuclear export sequence, whereas mislocalisation required the PB1 and UBA domains 
only. Thus, cytoplasmic mislocalisation was not necessarily required for TDP-43 cleavage to occur. Importantly, 
our results show that overexpression of p62 that is lacking either the PB1 or the UBA domains does not induce 
TDP-43 cleavage or mislocalisation. Of note, p62 overexpression exacerbates disease in a SOD1 mouse model 
of ALS and here we have shown that p62 overexpression leads to altered TDP-43-mediated RNA regulation 
consistent with reduced TDP-43 nuclear function. Thus, modulating p62 expression may present a potential 
therapeutic target for ALS and FTD-TDP. We are currently investigating the use of phosphorodiamidate mor-
pholino oligomers to regulate the expression of p62. Determination of the effects of p62 modulation on TDP-43 
pathology in ALS patient-derived neuronal cells is the subject of our future research.
Methods
Cell lines and treatments. All experiments described were carried out in NSC-34 motor neuron-like cells 
or mouse embryonic fibroblasts (MEFs). Wild type  (p62+/+) and p62 knockout  (p62−/−) MEFs were a generous 
gift from Professors Yu-shin Sou and Masaaki Komatsu, described  previously45. NSC-34 cells were maintained 
in Dulbecco’s modified essential medium (DMEM)/F12-Ham supplemented with 10% foetal calf serum in a 
37 °C incubator with 5%  CO2. MEF cells were maintained in DMEM with 10% foetal calf serum. Chemical treat-
ments were purchased from Sigma-Aldrich. Cells were incubated overnight with 2 μM MG132, 10 μM sodium 
arsenite or were heat shocked at 42 °C for 1 h, followed by 2 h recovery at 37 °C. For inhibitor assays, cells were 
pre-treated for 1 h with either 20 μM caspase inhibitor (Promega) or 5 calpain inhibitor (Sigma-Aldrich) or left 
untreated prior to transfection. Cells were maintained in media containing the inhibitors for 48 h post-trans-
fection. Cells were then fractionated into soluble and insoluble fractions and subjected to SDS polyacrylamide 
electrophoresis and western blotting.
Plasmids and transfections. Cells were transfected with constructs as indicated for 6–24 h. The pcDNA3.1, 
pcDNA3.1/EGFP, pcDNA3.1/EGFP-p62 (wild type and UBA deficient) were described  previously46. p62 dele-
tion constructs were a kind gift from Professor Terje  Johansen47. pcDNA3.1/TDP-43-tdTomato constructs were 
supplied by Professor Justin Yerbury. For soluble/insoluble fractionation experiments cells were grown in 6-well 
plates and transfected with 1.25 μg of pcDNA3.1/EGFP or pcDNA3.1/EGFP-p62 and 1.25 μg pcDNA3.1/TDP-
43-tdTomato unless otherwise indicated. For experiments investigating the effects of increasing p62 on TDP-43 
mislocalisation and cleavage, cells were grown in 6-well plates and transfected with 0.25, 0.5, 1, 1.5 or 2 μg of 
pcDNA3.1/EGFP-p62 and adjusted with 1.75, 1.5, 1, 0.5 or 0 μg of pcDNA3.1/EGFP respectively. All wells were 
also transfected with 1 μg pcDNA3.1/TDP-43-tdTomato. For transfection of cells with PMOs routinely used for 
knock-down of TDP-43 in our laboratory or a Genetools standard control (GTC), 1 ×  106 cells were resuspended 
in Buffer R. PMO was added at 100 μM. Cells were electroporated using the neon transfection tips as per manu-
facturer’s instructions (Invitrogen). The following day cells were transfected with 2 μg expression plasmids for 
either EGFP or EGFP-p62 and 48 h later were assessed for cell viability with Sytox Red by flow cytometry.
Cell fractionation (nuclear:cytoplasmic). p62+/+ or  p62−/− MEFs were fractionated following cell treat-
ments. Briefly, cells were lysed with 500 µL fractionation buffer (10 mM HEPES (4-2-hydroxyethyl-1-pipera-
zineethanesulfonic acid), 1.5 mM  MgCl2, 10 mM KCl, 0.5 μM dithiothreitol, 0.05% Tergitol, pH 7.9) on ice for 
10 min. Lysates were clarified by centrifugation at 3000 rpm at 4 °C for 10 min. Cytosolic supernatants were 
collected and frozen. The pellet was resuspended in 374 μL Buffer B (5 mM HEPES, 1.5 mM  MgCl2, 0.2 mM 
Ethylenediaminetetraacetic acid, 0.5 mM dithiothreitol, 26% Glycerol (v/v), pH 7.9) and 26 μL 4.6 M NaCl then 
passed through a 25-guage needle 10 times and then incubated on ice for 30 min. The lysates were centrifuged 
at 15,000 rpm at 4℃ for 30 min. Nuclear supernatants were collected.
Soluble and insoluble protein fractionation. NSC-34 cells were seeded into T25  cm2 flasks. The fol-
lowing day cells were transfected with an expression plasmid for TDP-43-tdTomato and either pcDNA3.1/EGFP, 
pcDNA3.1/EGFP-p62 wild type [WT] or deletion constructs as indicated. Forty-eight hours post-tranfection 
cells were lysed on ice with 1% Triton X-100 in phosphate buffered saline (PBS) supplemented with complete 
EDTA-free protease and phosphatase inhibitor cocktails. Lysates were freeze/thawed and then clarified by cen-
trifugation at 15,000g for 30 min at 4 °C and the 1% Triton X-100 soluble fractions were collected. The pellets 
were subsequently washed four times with 1% Triton X-100 in PBS and Triton-X insoluble proteins were solubi-
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lized with the addition of 1% SDS and incubated for 1 h at 60 °C. Triton X-100-insoluble fractions were collected 
following centrifugation at 15,000g for 30 min at 4 °C.
Western blot analyses. Protein samples were electrophoresed through SDS polyacrylamide gels and 
transferred to nitrocellulose membranes. Western blot analyses were performed as follows: membranes were 
blocked with 5% skim milk powder (SMP) in Tris-Buffered Saline (TBS) for 1 h at room temperature, mem-
branes were then incubated at room temperature with primary antibody as follows: anti-RFP (ThermoFisher) 
at a dilution of 1:1000 in 5% BSA in TBS-T for 2 h, anti-GFP (ThermoFisher) at a dilution of 1:5000 in 5% SMP 
in TBS with 0.05% Tween-20 (TBS-T) for 1 h, or anti-α-tubulin (Sigma-Aldrich) at a dilution of 1:10,000 in 5% 
SMP in TBS-T for 1 h. Membranes were washed 3× with TBS-T and then incubated with a species appropri-
ate horseradish peroxidase conjugated secondary antibody for 1 h at room temperature in 3% SMP in TBS-T. 
Membranes were washed 3× with TBS-T and protein bands visualised with enhanced Chemi-luminescence Plus 
reagent (Perkin Elmer). Membranes were stripped between western blots using mild stripping buffer (200 mM 
glycine, 3.5 mM sodium dodecyl sulphate, 0.2% Tween-20) and checked for residual signal with Chemilumines-
cence reagent (Perkin Elmer).
Densitometry. Densitometry of bands from Western blot analyses was performed using the in-built analy-
sis function in the BioRad ImageLab software. Data presented has been corrected to α-tubulin expression within 
samples and depicts the mean of ≥ 3 independent experiments +/− SEM.
Cell viability. For assessment of cell viability, NSC-34 cells were seeded into T25  cm2 flasks. Cells were 
transfected at various time points to allow for simultaneous assessment of viability at the following times post-
transfection; 96, 72, and 48 h. Cells were transfected with pcDNA3.1/EGFP-p62 (wild-type) and TDP-43-tdTo-
mato or suitable tagged-empty vector control. Cells were washed twice with 1 mL ice-cold PBS and transferred 
to 1.5 mL microfuge tubes and centrifuged at 1000 rpm for 2 min. Cells were resuspended in 200 µL ice-cold 
PBS + 2% FBS. A positive control sample was prepared by taking half of an untransfected sample and heating 
it at 65 °C for 1 min, followed by a 1 min incubation on ice. Half of the “killed” sample was resuspended in an 
equivalent volume of the remaining untransfected sample.
Samples were transferred to tubes and 0.2 µL SYTOX Red stain added to each sample that were then gen-
tly mixed and incubated at room temperature, shielded from light, for a minimum of 15 min. Samples were 
then analysed on a Fortessa flow cytometer, with 50,000 events collected per sample. A population of cells co-
expressing EGFP-p62 and TDP-43-tdTomato was created, and viability was assessed by measuring the amount 
of fluorescence in the SYTOX Red channel. SYTOX Red is an exclusion dye and only permeates the membrane 
of dead cells, therefore populations with higher fluorescence were considered non-viable. The kill control sample 
was used to define the gating parameters for the viable vs dead/non-viable cell population. For assessment of the 
effect of TDP-43 knockdown on p62 overexpression induced cytotoxicity, cells were electroporated with PMOs 
to knockdown TDP-43 expression or a PMO control and plated in a 6-well plate. The following day cells were 
transfected with 2 μg EGFP or EGFP-p62. Forty-eight hours later cells were collected and stained with Sytox 
Red then assessed by flow cytometry as described.
In‑gel trypsin digestion and liquid chromatography mass spectrometry (LC–MS). Triton-X 
insoluble fractions from cells transfected with TDP-43-tdTomato and either (i) pcDNA3.1 empty vector (cells 
were treated overnight with 10 μM MG132) or (ii) EGFP-p62WTtransfected (cells were left untreated) cells were 
separated in duplicate through 10% SDS polyacrylamide gels. One gel was Coomassie stained and destained 
in 7% acetic acid, 10% methanol while the second gel was transferred to nitrocellulose membrane and western 
blot analysis for TDP-43-tdTomato (anti-red fluorescence protein, RFP) was performed. Bands of ~ 90 kDa in 
the Coomassie stained gel were identified by comparison with the molecular weight of the TDP-43-tdTomato 
from the western blot results. The bands in the gel were excised and cut into 1–2 mm pieces and destained in 
50 mM ammonium bicarbonate pH 8, followed by 50 mM ammonium bicarbonate/50% acetonitrile pH 8. The 
destained gel pieces were dehydrated in 100% acetonitrile and the solution was removed to allow gel pieces to air 
dry. The proteins were reduced and alkylated with 10 mM DTT and 20 mM iodoacetamide (IAA) respectively 
and digested with trypsin (12.5 ng/µL) overnight at 37  °C as  described48. Following overnight digestion, the 
supernatant was transferred to a fresh tube and the tryptic peptides from the gel pieces were extracted twice with 
50% acetonitrile/2% formic acid and combined with the supernatants. The tryptic peptides were vacuum centri-
fuged to remove acetonitrile and desalted on a pre-equilibrated  C18 Omix tip. The eluted peptides were further 
dried under vacuum centrifugation until ~ 10 µL remained for LC–MS/MS analysis.
Tryptic peptides were separated on a Ultimate 3000 (ThermoFisher) equipped with a Thermo Acclaim™ 
PepMap™ 100  C18 column (75 µm diameter, 3 µm particle size, 150 mm length) employing a 60 min gradient 
(2–26% v/v acetonitrile, 0.1% v/v formic acid for 40 min followed by 50% v/v acetonitrile, 0.1% v/v formic acid 
for 10 min and 80% v/v acetonitrile, 0.1% v/v formic acid for 8 min) with a flow rate of 300 nL/min. The peptides 
were eluted and ionized into Q-Exactive Plus mass spectrometer (ThermoFisher). The electrospray source was 
fitted with an emitter tip 10 μm (ThermoFisher) and maintained at 1.6 kV electrospray voltage. FTMS analysis 
was carried out with a 70,000 resolution and an AGC target of 1 ×  106 ions in full MS (m/z range 400–2000); 
and MS/MS scans were carried out at 17,500 resolution with an AGC target of 2 ×  104 ions. Maximum injection 
times were set to 30 and 50 ms respectively. A top-10 method was employed for MS/MS selection, ion selection 
threshold for triggering MS/MS fragmentation was set to 1 ×  104 counts, isolation width of 2.0 Da, and dynamic 
exclusion for 20 s was used to perform HCD fragmentation with normalised collision energy of 27.
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Raw spectra files were processed using the Proteome Discoverer 2.2 software (ThermoFisher) incorporating 
the Sequest search algorithm. Peptide identifications were determined using a 20-ppm precursor ion tolerance 
and a 0.1 Da MS/MS fragment ion tolerance for FTMS and HCD fragmentation. Carbamidomethylation modi-
fication of cysteines was considered a static modification while oxidation of methionine, and acetyl modification 
on N-terminal residues were set as variable modifications allowing for maximum two missed cleavages. The data 
was processed through Percolator for estimation of false discovery rates. Protein identifications were validated 
employing a q-value of 0.01.
Confocal microscopy. To enable separation of single cells for better imaging, cells were transfected and 
then reseeded onto coverslips the following day. Briefly, NSC-34 cells were transfected in 6-well plates with 
expression vectors for TDP-43-tdTomato (wild type [WT] or mutant [p.M337V] and either pcDNA3.1-EGFP 
(empty vector [EV]), pcDNA3.1-EGFP p62 (WT or deletion constructs as indicated). The following day cells 
were trypsinised and reseeded onto Poly-L-Lysine coated coverslips in 6-well plates. The following day 48 h post-
transfection cells were washed 2 times with PBS and then fixed with 4% paraformaldehyde in PBS for 20 min, 
followed by washing 3 times with PBS. Coverslips were incubated with Hoechst 33342 (ThermoFisher) dye 
diluted 1:10,000 in PBS for 10 min at room temperature. Cells were washed 3 times with PBS and the coverslips 
mounted onto slides using Prolong Gold antifade mounting media (ThermoFisher). Images were taken using a 
Nikon A1 confocal microscope using a 40× oil objective. Pearson’s co-efficient to determine the co-localisation 
of TDP-43-tdTomato with Hoechst nuclear stain was performed using the co-loc 2 plug in for ImageJ on cell 
images taken from 3 independent replicate experiments (minimum 32 cells per transfection). A Pearson’s co-
efficient of > 0.6 indicates co-localisation.
RNA extraction and RT‑PRC. NSC-34 cells were transfected with p62 overexpression plasmids or an 
empty vector, as above, and incubated for 1, 3 or 5 days prior to harvesting for transcript analysis. RNA was iso-
lated from cells using a MagMAX total RNA isolation kit, including a DNase treatment (Life Technologies), per-
formed using a Kingfisher RNA extractor, according to the manufacturer’s protocol. RT-PCRs were performed 
using a One-step SuperScript III RT-PCR kit with platinum Taq polymerase (Life Technologies), according 
the manufacturer’s instructions. Each reaction contained 50 ng of RNA and 25 ng of each forward and reverse 
primer, with the primer sequences and PCR cycling conditions listed in Table 2. PCR products were separated 
on a 2% agarose gel, stained using RedSafe (Scientifix) and visualised on a Vilber Lourmat Fusion FX system. 
Densitometry was performed using Bio1D software.
Statistical analyses. All statistical analyses were performed in SPSS Version 24.0.0.0. The significance of 
differences between means was determined using the One-way analysis of variance with post-hoc Bonferroni 
test with significance set at p ≤ 0.05.
Table 2.  Primer sequences and RT-PCR conditions for Stag2, Poldip3, Madd and Smn transcript amplification.
Transcript and size Primer Primer sequence Temperature profile
Stag2 Exon 29 Fwd GGC ATG CAA CTA GCA CTC C 55 °C 30 min
+ 30b 346 bp Exon 32 Rev CTT CCA TTA GGC TTG TAC CACG 94 °C 2 min
Δ30b 235 bp 94 °C 40 s
55 °C 30 s 28 cycles
68 °C 1 min
Poldip3 Exon 2 Fwd CCG GTT TCG GAT CAA AGG GA 55 °C 30 min
FL 349 bp Exon 4 Rev CAT CTG CTT GGG AGG GAC AG 94 °C 2 min
Δ3 260 bp 94 °C 40 s
55 °C 30 s 30 cycles
68 °C 1 min
Madd Exon 27 Fwd CTG CGT GGT GTT GCG TAG TA 55 °C 30 min
FL 349 bp Exon 30/31 GAA AAC CTT CCG CTC CTG GTTG 94 °C 2 min
Rev 94 °C 40 s
55 °C 30 s 32 cycles
68 °C 1 min
Smn Exon 4 Fwd GAA AGT CAA GTT TCC ACA GACG 55 °C 30 min
FL 430 bp Exon 8 Rev CAC CCC ATC TCC TGA GAC AGAGC 94 °C 2 min
94 °C 40 s
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